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The aim of this study was to investigate whether influenza neuraminidase travels directly from the Golgi complex to the 
apical domain of the plasma membrane in virally infected epithelial (MDCK) cell monolayers, or whether it passes tran- 
siently through the basolateral domain. Using a new assay for the delivery of neuraminidase to the plasma membrane, 
we found that the time course of transport of this protein from the Golgi complex to the apical surface of MDCK cell 
monolayers was very similar to that for influenza haemagglutinin, which is known to be delivered directly to its destina- 
tion. In addition, a similar time course of neuraminidase transport was found in BHK cells, which are not asymmetric 
and in which delivery must therefore be direct. Finally, basolateral exposure of MDCK cell monolayers grown on nitro- 
cellulose filters to an anti-neuraminidase antibody was shown to have no effect on the delivery of active neuraminidase 
to the apical surface. We conclude from these results that neuraminidase, like haemagglutinin, is delivered directly to 
the apical surface. 
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1. INTRODUCTION 
Ideas about the sorting of plasma membrane 
proteins in MDCK cell monolayers, an extensively 
investigated model epithelium, have been based 
largely on the behaviour of two proteins, the 
apically targetted influenza haemagglutinin and 
the basolaterally targetted vesicular stomatitis 
virus (VSV) G-protein [1,2]. After synthesis, these 
proteins move together through the Golgi complex 
and are apparently segregated as they leave this 
organelle, for delivery to their different destina- 
tions [3-61. A different sorting mechanism 
operates in the hepatocyte. Here proteins destined 
for both the basolateral and apical domains of the 
plasma membrane are transported initially to the 
basolateral domain, from .where apical proteins are 
moved on to their final location [7]. 
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In order to strengthen the argument hat the sor- 
ting mechanisms in these two cell types are fun- 
damentally different, we have examined the route 
taken between the Golgi complex and the plasma 
membrane of MDCK cell monolayers by influenza 
neuraminidase, another protein that is targetted to 
the apical surface. We present evidence that 
neuraminidase, like haemagglutinin, is delivered 
directly to the apical surface. 
2. MATERIALS AND METHODS 
MDCK cells (strain II) obtained initially from Dr K. Simons 
(EMBL, Heidelberg) were grown as monolayers in Eagle’s 
minimum essential medium (EMEM) supplemented with 10% 
(v/v) newborn calf serum, non-essential amino acids and 
50 ItJ/ml penicillin/50 pg/ml streptomycin. Baby hamster 
kidney (BHK-21) cells, obtained from Flow Labs 
(Rickmansworth, England), were grown in Glasgow’s minimum 
essential medium (GMEM) supplemented with 10% newborn 
calf serum, 10% tryptose phosphate broth and penicillin/strep- 
tomycin. All media and supplements were obtained from Flow 
Labs. 
The WSN strain of influenza virus was obtained from Dr 
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S.C. Inglis (Department of Pathology, University of Cam- 
bridge). The X-31 strain of influenza virus, and a monoclonal 
antibody (as ascites fluid) to the X-31 neuraminidase, were ob- 
tained from Dr A. Hay (NIMR, Mill Hill, London). Semliki 
Forest virus (SFV) was obtained from Dr T.R. Hesketh (Depar- 
ment of Biochemistry, University of Cambridge). All viruses 
were propagated as described [B]. [‘H]SFV was prepared in the 
same way as SFV, except that post-infection maintenance 
medium contained N-[‘Hlacetyl-D-mannosamine (30 Ci/ 
mmol; NEN, Stevenage, England). The envelope proteins of 
progeny virions consequently contained [3H]sialic acid [9]. 
Neuraminidase at the cell surface was detected through its 
ability to cleave [3H]sialic acid from [‘H)SFV. Confluent 
monolayers of MDCK cells, growing either on 3 cm diameter 
plastic dishes or on 2.5 cm diameter nitrocellulose filters 
(0.45 pm pore size; Millipore, Harrow, England) in perspex 
chambers, were washed twice with 2 ml EMEM containing 
0.2% (w/v) bovine serum albumin (BSA) and infected with > 10 
plaque-forming units/cell of influenza virus in the same 
medium for 1 h at 37°C. The medium was then replaced with 
EMEM containing 2% newborn calf serum. At var,ious times 
after infection monolayers were washed twice with 2 ml ice-cold 
phosphate-buffered saline containing 0.9 mM CaCl2 and 
0.5 mM MgClz (PBS) and exposed to [‘HISFV (approx. 
13000 dpm) in 0.5 ml PBS containing 2 mg/ml BSA for 30 min 
at 4°C (WSN strain) or 37°C (x 31 strain) with gentle rocking. 
Protein was precipitated by addition of 10% (w/v) trichloro- 
acetic acid, followed by incubation on ice for 30 min. Protein 
was pelleted by centrifugation for 2 min in an Eppendorf 
microfuge. Supernatants were removed and radioactivity was 
counted by liquid scintillation spectroscopy. We have shown 
previously [B] that the release of [3H]sialic acid from [3H]SFV 
is linear over both the 30 min incubation period and the range 
of neuraminidase activities used in this study. 
3. RESULTS AND DISCUSSION 
We used two approaches in investigating the 
route taken by influenza neuraminidase from the 
Golgi complex to the apical domain of the plasma 
membrane. First, we measured the time taken for 
the enzyme to travel between the two compart- 
ments, and compared this time with the transfer 
time previously reported for haemagglutinin in the 
same cells and also with the time taken for 
neuraminidase to move between the same two 
compartments in a non-asymmetric ell (BHK), in 
which the transfer must be direct. Second, we ex- 
amined the effect of an inactivating antibody to 
neuraminidase, placed on the basolateral side of an 
MDCK cell monolayer, on the rate of delivery of 
active enzyme to the apical surface. We reasoned 
that if neuraminidase travels to the apical surface 
via the basolateral surface, then the presence of an 
antibody on the basolateral side should either 
cause the neuraminidase to be retained at this sur- 
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face or result in the delivery of inactivated enzyme 
to the apical surface. 
In order to examine the time course of transit of 
neuraminidase between the trans elements of the 
Golgi complex and the plasma membrane, we ex- 
ploited the observation that reduction of the in- 
cubation temperature to 20°C causes a reversible 
block in the intracellular transport of several 
plasma membrane proteins [ IO,1 11, including 
neuraminidase in MDCK cells [6], at the point at 
which they normally leave the Golgi complex. The 
compartment in which the proteins are blocked has 
been termed the trans Golgi network [ 121. Our aim 
was to stack neuraminidase in this late Golgi com- 
partment and then release the block by warming 
the cells to 37”C, thus allowing a bolus of enzyme 
to move synchronously out to the plasma mem- 
brane. To keep this bolus as compact as possible, 
we inhibited further synthesis of neuraminidase by 
addition of cycloheximide after the low- 
temperature block was applied. 
The effect of incubation at 20°C on the rate of 
delivery of neuraminidase to the apical domain of 
the plasma membrane in MDCK monolayers 
grown on plastic dishes is shown in fig. 1. In con- 
trol cells, neuraminidase activity at the cell surface 
is just detectable at 3 h post-infection. Surface ac- 
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Fig.1. Effect of low-temperature incubation on the rate of 
delivery of neuraminidase to the cell surface in MDCK cell 
monolayers. MDCK cell monolayers, grown on plastic dishes, 
were infected with influenza virus (WSN) and incubated from 
3 h post-infection at either 37’C (0) or 20°C (+), and surface 
neuraminidase activity determined at 4°C. Values are means f
SE (n = 3). 
Volume 244, number 1 FEBS LETTERS February 1989 
tivity then rises in an approximately linear manner 
between 3 and 5 h and eventually reaches a plateau 
after 7 h, presumably when the rate of delivery to 
the surface is balanced by the rate of loss through 
viral budding [8]. In cells incubated at 20°C from 
3 h post-infection, there is very little increase in 
neuraminidase activity at the cell surface. At 7 h 
post-infection, for example, [3H]sialic acid release 
is 3.1% compared with 15.2% in control cells. 
Hence, low-temperature incubation causes an 
almost complete block in the delivery of 
neuraminidase to the cell surface. 
To measure the time course of delivery of 
neuraminidase to the cell surface following a low- 
temperature block, MDCK cell monolayers grown 
on plastic dishes were incubated at 37°C for 3 h 
and then transferred to 20°C. After 1 h at low 
temperature, cycloheximide (20 pg/ml) was added 
to inhibit protein synthesis. After a further 30 min 
at 2O”C, cells were warmed to 37°C and the activi- 
ty of neuraminidase at the cell surface was 
measured at various times after warm-up. The 
results obtained are shown in fig.2. Delivery of 
neuraminidase to the cell surface was almost com- 
plete after 30 min, as has previously been shown 
for haemagglutinin [5]. Between 60 and 90 min, 
surface neuraminidase activity declined to 
baseline, because enzyme was lost through viral 
budding. No significant neuraminidase activity 
was detected at the surface of monolayers that had 
not been warmed to 37°C. 
A similar experiment to that described above 
was carried out with BHK cells. The results obtain- 
ed are shown in fig.3. In these cells, surface 
neuraminidase activity rises linearly over the first 
60 min after warm-up, and then reaches a plateau. 
There is no detectable decline in activity between 
60 and 90 min, in contrast to the situation in 
MDCK cells. Again, neuraminidase is not 
delivered to the cell surface in cells kept at 20°C. 
The results presented so far indicate that 
neuraminidase is transported directly from the 
Golgi complex to the apical domain of the plasma 
membrane. We cannot,. however, exclude the 
possibility that neuraminidase does pass through 
the basolateral domain but moves so quickly 
through the cell that it arrives at the apical domain 
at the same time as haemagglutinin, which travels 
directly to its destination. To test this possibility 
directly, we exposed confluent MDCK cell 
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Fig.2. Time course of transport of neuraminidase from the 
tram Golgi network to the cell surface in MDCK cell 
monolayers. MDCK cell monolayers, grown on plastic dishes, 
were infected with influenza virus (WSN) and incubated at 
37°C until 3 h post-infection. The temperature was then 
reduced to 2O’C. After 1 h, medium containing cycloheximide 
(20 @g/ml) was added and the low-temperature incubation was 
continued for a further 30 min. The cells were then warmed to 
37°C for various times (0) or kept at 20°C (+), and surface 
neuraminidase activity determined as described in fig. 1. Values 
are means & SE (n = 3). 
monolayers, grown on nitrocellulose filters, to an 
anti-neuraminidase monoclonal antibody, either 
on the apical side or the basolateral side, and ex- 
amined its effect on the delivery of neuraminidase 
to the apical surface. Antibody (ascites fluid 
gl 
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Fig.3. Time course of transport of neuraminidase from the 
tram Golgi network to the cell surface in BHK cells. Methods 
as described in fig.2. Values are means _+ SE (n = 3). 
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Fig.4. Effect of an anti-neuraminidase antibody on 
neuraminidase activity at the apical surface of MDCK cell 
monolayers. MDCK cell monolayers, grown on nitrocellulose 
filters, were infected with influenza virus (X-31) and exposed 
from 3 h post-infection to either normal medium or medium 
containing a monoclonal antibody to neuraminidase. Antibody 
was present on either the apical or the basolateral side of the 
monolayer. In addition, some monolayers were exposed on the 
apical side to antibody-containing medium that had been 
previously passed through a filter. Neuraminidase activity at the 
apical surface was determined 6 h post-infection at 37°C. 
Values are means + SE (n 3 9, except for the filtered medium 
condition, where n = 3). 
diluted 1: 1000) was present in the medium bathing 
the cells from 3 to 6 h post-infection. We found 
that in control cells there was an increase in surface 
neuraminidase activity between 3 and 6 h, and that 
this increase was abolished by the presence of the 
antibody in the apical bathing medium (fig.4). An- 
tibody in the basolateral medium, on the other 
hand, had no effect on the increase in enzyme ac- 
tivity at the apical surface. Fig.4 also shows that 
medium containing antibody that had been allow- 
ed to pass through a filter, was still able to inhibit 
neuraminidase activity. Hence, antibody in the 
basolateral bathing medium, although able to pass 
freely through the filter, does not affect the 
delivery of neuraminidase to the apical surface. 
We have shown, therefore, that influenza 
neuraminidase, like haemagglutinin, is delivered 
directly to the apical domain of the plasma mem- 
brane in MDCK cell monolayers. This result in- 
dicates that the delivery of apically targetted 
membrane proteins directly to their destination 
may be a general mechanism in MDCK cells, and 
strengthens the argument that these cells differ 
fundamentally from, for example, hepatocytes in 
the way in which plasma membrane proteins are 
processed. Whether MDCK cells handle en- 
dogenous apical membrane proteins in the same 
way is at present unknown. 
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